| Old Articles: <Older 24441-24450 Newer> |
 |
The Motley Fool July 12, 2007 Emil Lee |
Fight for Your Rights Offering The key to rights offerings is not to make mistakes. Even if you don't want additional shares, make sure you manage your rights in a way that won't cost you money.  |
The Motley Fool July 12, 2007 Brian Lawler |
Dendreon Under Attack Following an unfavorable regulatory decision for its lead drug Provenge, the biotech is now the focus of an SEC inquiry.  |
The Motley Fool July 12, 2007 Lawrence Rothman |
Not Another Sale at Kohl's! More excuses from the retailer. Apparently, Memorial Day was early this year and May sales counted. Investors, take note.  |
The Motley Fool July 12, 2007 Brian Lawler |
Is It Time to Buy Genentech Yet? Genentech announces positive second-quarter results, but investors remain worried.  |
The Motley Fool July 12, 2007 Mike Cianciolo |
Leveling Off at Aeropostale The retailer posts modest gains in total sales and comps. Investors, take note.  |
The Motley Fool July 12, 2007 David Lee Smith |
Her Name Is Rio and She Dances With Alcan Alcoa's offer for Canadian rival Alcan is trumped by white knight Rio Tinto. Savvy investors should monitor the mining industry closely. Perhaps the biggest deals in the metals race are yet to surface.  |
The Motley Fool July 12, 2007 Brian Orelli |
Supporting the Little Company Tercica gets a partnership with Genentech. As part of the deal, Genentech will purchase $4 million in Tercica stock for about $5.65 per share. Some investors think that Genentech is underpaying.  |
The Motley Fool July 12, 2007 Rich Duprey |
Backdating Boredom It seems everyone from investors to the justice system is tiring of the stock options scandal.  |
The Motley Fool July 12, 2007 Jeremy MacNealy |
Fool on Call: Chattem Looks Toward a Record '08 Timely acquisitions and cost savings add up to a big year for this consumer-goods producer. Prospective investors should at least take a closer look.  |
The Motley Fool July 12, 2007 Ryan Fuhrmann |
Will Ruby Tuesday Shine Again? Ruby Tuesday has some work to do to revitalize its brand. Investors, take note.  |
| <Older 24441-24450 Newer> Return to current articles. |